Research in Peds Heme\Onc at UCLA and the Mattel Children's Hospital

UCLA is a Major Center for Basic Science and Clinical Research

UCLA provides a wide spectrum of research opportunities. The Howard Hughes Institute and the Molecular Biology Institute are just two examples of the infrastructure of basic research at the University that is available to our fellows. For trainees more inclined toward translational and clinical investigation, the UCLA-Jonsson Comprehensive Cancer Center, The Rand Corporation, and the UCLA School of Public Health provide a milieu in which developing clinical investigators will flourish. The School of Public Health offers a program of coursework including the option of completing a Masters degree in Public Health. The School of Medicine now offers a Masters Degree in Clinical Investigation. For those trainees dedicated to the development of innovative educational approaches to our field, the School of Education provides an environment in which novel tools and ideas can be developed or adapted

The Pediatric Hematology & Oncology Program has been a participant in Pediatric Clinical Trials for over 25 years. Greater than ninety percent of all pediatric oncology patients in this program are enrolled on at least one clinical trial. The majority of patients are on at least two trials. The program is an active participant in several large pediatric cooperative groups. We have been funded members of the Children's Oncology Group (formerly CCSG and CCG) since 1976 and have participated in many of their research studies (clinical, epidemiologic and biologic). We have been participating in the COBLT trial since that trial's inception. We have recently joined the Pediatric Bone Marrow Transplant Consortium (PBMTC), which is one of fourteen recently awarded Clinical Core Centers in the new NHLBI Blood and Marrow Transplant Clinical Trials Network (CTN) and are active participants. In addition, we participate in smaller consortiums that allow performance of smaller pilot studies. This includes the Pediatric Cancer Research Foundation Consortium (PCRFC) as well as various drug trials emanating from pharmaceutical companies. There is active involvement of the pediatric oncology staff on various cancer center committees and faculty members assess new protocols for their potential suitability and application to the pediatric oncology population. This includes membership on the ISPRC, Leukemia Research Study Group and other committees.

For more information, and for information of specific basic science research programs, please also browse the pages for individual faculty members and the UCLA Access program